Gordon Lavigne, MEd, CEO of the Schizophrenia & Psychosis Action Alliance, talk about the joint FDA committee's vote on clozapine REMS.
Gordon Lavigne, MEd
Advertisement
Mr Lavigne is the chief executive officer of the Schizophrenia & Psychosis Action Alliance.
Articles by Gordon Lavigne, MEd
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Innovation in Schizophrenia Treatment: Evenamide Research With Anthony Grace, PhD
2
Lumateperone as an Adjunctive Therapy for MDD: In Conversation With the Primary Investigator
3
Hyperbaric Oxygen Therapy: An Innovative PTSD Treatment for Veterans
4
Let’s Retire Haloperidol
5
